Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Increased antibody levels to stage-specific Epstein-Barr virus antigens in systemic autoimmune diseases reveal a common pathology

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Denosumab vs. zoledronic acid treatment in post-menopausal breast cancer: a 2-year prospective observational study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Quantification of biotin in plasma samples by column switching liquid chromatography - tandem mass spectrometry

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Prognostic utility of serum YKL-40 in patients with cervical cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Circadian variations in plasma concentrations of cholecystokinin and gastrin in man

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Early life body size, growth and risks of systemic lupus erythematosus - A large Danish observational cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic: a letter to clinicians

    Research output: Contribution to journalLetterResearchpeer-review

View graph of relations

The immune responses to antigens from different stages of the Epstein-Barr virus (EBV) life cycle were investigated in systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), Sjögren's syndrome (SS), and systemic sclerosis (SSc) to gain knowledge of EBV's involvement in the etiology of systemic autoimmune diseases (SADs) and for an overview of the humoral immune responses against EBV. Investigations were performed by the use of ELISA. IgM, IgA, and IgG antibody binding to 11 EBV antigens: EBNA1, EBNA2, BALF5, EAD, BALF2, EA/R, VCA p18, VCA p23, gB, gp350, and gp42 were examined in serum pools from SAD patients and healthy controls (HCs). Increased antibody levels against the 11 EBV antigens in the SAD pools were seen compared to the HC pool. Specifically, SLE was characterized by strongly increased IgA to EAD both compared to HCs and other SADs, and RA was characterized by increased IgM levels to several EBV antigens. The SADs may be partly distinguished by their differential immune responses to various antigens in the EBV life cycle. All together, these findings support an association between EBV infection and SADs.

Original languageEnglish
JournalScandinavian Journal of Clinical and Laboratory Investigation
Volume79
Issue number1-2
Pages (from-to)7-16
Number of pages10
ISSN0036-5513
DOIs
Publication statusPublished - 8 Feb 2019

    Research areas

  • Adult, Aged, Aged, 80 and over, Antibodies, Viral/blood, Antigens, Viral/blood, Arthritis, Rheumatoid/diagnosis, Case-Control Studies, Epstein-Barr Virus Infections/diagnosis, Female, Herpesvirus 4, Human/growth & development, Humans, Immunity, Humoral, Immunoglobulin A/blood, Immunoglobulin G/blood, Immunoglobulin M/blood, Lupus Erythematosus, Systemic/diagnosis, Male, Middle Aged, Scleroderma, Systemic/diagnosis, Sjogren's Syndrome/diagnosis

ID: 58902460